Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...
The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker said on Tuesday, paving the ...
MedPage Today on MSNOpinion
'Most Favored Nation' Pricing May Cut Drug Costs. It May Also Cut Off Rural America.
In November, the Trump administration resurrected a Most Favored Nation (MFN) reference pricing policy, which would tie drug ...
Zacks.com on MSN
CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike
CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion ...
Grifols S.A. has received certification from the European Medicines Agency (EMA) for the entire value chain of Grifols Egypt ...
Pharmaceutical Technology on MSN
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has applied to the EMA to expand the label for Anzupgo (delgocitinib) cream to include adolescents.
ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...
An update from Grifols SA ( ($GRFS) ) is now available. On December 11, 2025, Grifols, S.A. announced that the European Medicines Agency (EMA) ...
IDMP standards aim to improve medicinal product data management but have faced delays, limiting their benefits for the life ...
The European Commission has today proposed an ambitious package of measures to improve the health of EU citizens, while ...
Laru-zova is investigational and has not been approved by FDA for use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback